Bio­gen shrugs off $1B-plus gene ther­a­py pact af­ter PhI/II im­plo­sion — AGTC shares crater

More than 3 years af­ter Bio­gen $BI­IB front­ed their $1 bil­lion-plus pact with Flori­da-based biotech AGTC with $124 mil­lion in cash to build their new …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.